Xeris Biopharma Inc. (XERS) Business Metric Overview - Stocknear

Xeris Biopharma Inc.

NASDAQ: XERS · Real-Time Price · USD
7.85
-0.04 (-0.51%)
At close: Sep 05, 2025, 3:59 PM
7.86
0.13%
After-hours: Sep 05, 2025, 07:49 PM EDT

Xeris Biopharma Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022
Keveyis Revenue 11.48M 11.43M 24.25M 12.19M 13.13M 13.09M 40.91M 15.87M 14.09M 12.76M 13.8M 13.37M 12.81M
Keveyis Revenue Growth +0.51% -52.88% +98.90% -7.12% +0.33% -68.01% +157.84% +12.61% +10.45% -7.58% +3.22% +4.36% n/a
Product Revenue 67.71M 57.8M 103.51M 52.86M 46.51M 40.26M 111.67M 41.7M 36.89M 32.27M 32.54M 29.55M 25.26M
Product Revenue Growth +17.14% -44.16% +95.82% +13.65% +15.52% -63.94% +167.81% +13.02% +14.34% -0.84% +10.10% +17.00% n/a
Product, Other Revenue 1.31M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product, Other Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selling, General, and Administrative Revenue 44.39M 44.02M 40.14M 44.97M 39.99M 38.38M 37.57M 37.29M 37.63M 33.6M 34.36M 34.49M 32.98M 35.91M 54.18M 26.54M 25.93M 19.08M 18M 16.48M 17.64M 21.61M 20.64M 14.88M 15.02M 12.52M 8.72M 4.65M 4.5M 3.24M 3.1M 2.02M 1.56M 1.34M
Selling, General, and Administrative Revenue Growth +0.85% +9.66% -10.74% +12.44% +4.20% +2.16% +0.75% -0.92% +11.99% -2.19% -0.39% +4.57% -8.16% -33.71% +104.18% +2.35% +35.91% +6.00% +9.18% -6.57% -18.34% +4.67% +38.75% -0.98% +20.02% +43.47% +87.63% +3.36% +38.90% +4.55% +53.59% +29.38% +16.26% n/a
Research and Development Revenue 8.05M 7.75M 6.09M 5.89M 5.76M 7.82M 6.38M 5.03M 6.09M 4.84M 4.96M 6.04M 3.72M 6.25M 10.08M 5.66M 5.38M 4.03M 5.11M 3.88M 5.29M 6.65M 12.42M 15.52M 19.33M 13.17M 12.39M 10.88M 8.68M 8.71M 6.58M 5.72M 4.2M 3.66M
Research and Development Revenue Growth +3.90% +27.27% +3.46% +2.24% -26.36% +22.55% +26.78% -17.30% +25.82% -2.36% -18.00% +62.53% -40.51% -38.01% +78.03% +5.20% +33.51% -21.10% +31.84% -26.72% -20.42% -46.49% -19.96% -19.73% +46.83% +6.27% +13.93% +25.33% -0.40% +32.44% +14.90% +36.28% +14.72% n/a